Endovascular therapy of acute ischemic stroke

Expert Opinion on Pharmacotherapy

Volumn 12, Issue 6, 2011, Pages 913-930

  Raychev, Radoslav ^a   Ovbiagele, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acute stroke; cerebral ischemia; clot retrieval; endovascular; interventional; intra arterial; intracerebral hemorrhage; recanalization; reperfusion; thrombolysis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; NASARUPLASE BETA; PROUROKINASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ANGIOPLASTY; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; DRUG SAFETY; ENDOVASCULAR THERAPY; FIBRINOLYTIC THERAPY; HUMAN; LOW DRUG DOSE; MECHANICAL THROMBECTOMY; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PROGNOSIS; REVIEW; STENT; THERAPY; THERAPY EFFECT; THROMBUS ASPIRATION; TREATMENT OUTCOME;

ACUTE DISEASE; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; ENDOVASCULAR PROCEDURES; HUMANS; INJECTIONS, INTRAVENOUS; NEUROSURGICAL PROCEDURES; STROKE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; THROMBECTOMY; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79952744501     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2011.543897     Document Type: Review

References (73)

1. National Institute ofNeurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7
2. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29
3. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
4. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome-a meta-analysis. Stroke 2007;38:967-73 (Pubitemid 46568460)
5. Ciccone A, Valvassori L, Gasparotti R, et al. Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke 2007;38:2191-5 (Pubitemid 47012289)
6. Hussein HM, Georgiadis AL, Vazquez G, et al. Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study. Am J Neuroradiol 2010;31:454-8
7. Hallevi H, Barreto AD, Liebeskind DS, et al. The HIAT score: identifying patients at high risk for poor outcome after intra arterial therapy for acute ischemic stroke. Stroke 2009;40:E164
8. De Silva DA, Ebinger M, Christensen S, et al. Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial. Cerebrovasc Dis 2009;29:14-21
9. Wechsler LR, Roberts R, Furlan AJ, et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003;34:1224-9 (Pubitemid 36547518)
10. Hill MD, Rowley HA, Adler F, et al. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925-31 (Pubitemid 36944782)
11. Campbell BC, Christensen S, Butcher KS, et al. Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke. Stroke 2010;41:82-8
12. De Silva DA, Brekenfeld C, Ebinger M, et al. The benefits of intravenous thrombolysis relate to the site of baseline arterial occlusion in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET). Stroke 2010;41:295-9
13. Bang OY, Saver JL, Alger JR, et al. Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke 2009;40:454-61
14. Liebeskind DS. Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics. Curr Opin Neurol 2010;23:36-45
15. del Zoppo GJ. Virchow's triad: the vascular basis of cerebral injury. Rev Neurol Dis 2008;5(Suppl 1):S12-21
16. Kasner SE. Clinical interpretation and use of stroke scales. Lancet Neurol 2006;5:603-12 (Pubitemid 43867434)
17. Saver JL. Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harm. Stroke 2007;38:2279-83 (Pubitemid 47457569)
18. Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-37
19. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-8 (Pubitemid 40967507)
20. Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-72
21. Saver JL. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol 2004;61:1066-70 (Pubitemid 38915948)
22. Saver JL, Gornbein J, Grotta J, et al. Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3-to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke 2009;40:2433-7
23. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-25
24. Hacke W, Ringleb P, Stingele R How did the results of ECASS II influence clinical practice of treatment of acute stroke. Rev Neurol 1999;29:638-41
25. Clark WM, Albers GW, Madden KP, et al.; Thromblytic Therapy in Acute Ischemic Stroke Study Investigators. The rtPA (alteplase) 0-to 6-hour acute stroke trial, partA (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke 2000;31:811-16 (Pubitemid 30198420)
26. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670-4 (Pubitemid 30248478)
27. Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke 2006;37:979-85
28. Baird AE, Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998;18:583-609 (Pubitemid 28262455)
29. Schlaug G, Benfield A, Baird AE, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 1999;53:1528-37 (Pubitemid 29491949)
30. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 2010;41:1996-2000
31. Parsons MW, Christensen S, McElduff P, et al. Pretreatment diffusion-and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab 2010;30:1214-25
32. Campbell BC, Christensen S, Foster SJ, et al. Visual assessment of perfusion-diffusion mismatch is inadequate to select patients for thrombolysis. Cerebrovasc Dis 2010;29:592-6
33. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2009;41:e25-33
34. Loh Y, Towfighi A, Liebeskind DS, et al. Basal ganglionic infarction before mechanical thrombectomy predicts poor outcome. Stroke 2009;40:3315-20
35. Levy EI, Firlik AD, Wisniewski S, et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999;45:539-45
36. Smith WS. Intra-arterial thrombolytic therapy for acute basilar occlusion: pro. Stroke 2007;38(2 Suppl):701-3 (Pubitemid 46188250)
37. Zeumer H, Hacke W, Ringelstein EB. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol 1983;4:401-4
38. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-9 (Pubitemid 47493996)
39. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke 2010;41:932-7
40. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-82 (Pubitemid 44897621)
41. Hussain MS, Kelly ME, Moskowitz SI, et al. Mechanical thrombectomy for acute stroke with the alligator retrieval device. Stroke 2009;40:3784-8
42. Gonzalez A, Mayol A, Martinez E, et al. Mechanical thrombectomy with snare in patients with acute ischemic stroke. Neuroradiology 2007;49:365-72 (Pubitemid 46510892)
43. Clark W, Lutsep H, Barnwell S, et al. The penumbra pivotal stroke trial. safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-8
44. Zaidat OO, Wolfe T, Hussain SI, et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008;39:2392-5
45. Levy EI, Mehta R, Gupta R, et al. Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007;28:816-22 (Pubitemid 46776054)
46. Levy EI, Siddiqui AH, Crumlish A, et al. First food and drug administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009;40:3552-6
47. Mocco J, Hanel RA, Sharma J, et al. Use of a vascular reconstruction device to salvage acute ischemic occlusions refractory to traditional endovascular recanalization methods. J Neurosurg 2010;112:557-62
48. Alexander MJ, Duckwiler GR, Gobin YP, Vinuela F. Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: technical case report. Neurosurgery 2002;50:899-902 (Pubitemid 36322822)
49. Velat GJ, Burry MV, Eskioglu E, et al. The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol 2006;65:352-9
50. Abou-Chebl A, Bajzer CT, Krieger DW, et al. Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis. Stroke 2005;36:2286-8 (Pubitemid 41429263)
51. Memon MZ, Natarajan SK, Sharma J, et al. Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke. Journal of Neurosurgery 24 Sep 2010 [Epub ahead of print]
52. Qureshi AI, Saad M, Zaidat OO, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002;33:1916-19 (Pubitemid 34761085)
53. Adams HP Jr, Effron MB, Torner J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008;39:87-99
54. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976-82
55. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-54 (Pubitemid 46568457)
56. Wolfe T, Suarez JI, Tarr RW, et al. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008;17:121-8 (Pubitemid 351626608)
57. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802-9
58. Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:80-4 (Pubitemid 46035610)
59. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-11
60. The Interventional Management of Stroke (IMS) II Study. Stroke 2007;38:2127-35
61. Tomsick T, Broderick J, CarrozellaJ, et al. Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008;29:582-7 (Pubitemid 351424079)
62. Khatri P, Hill MD, Palesch YY, et al. Methodology of the interventional management of stroke III trial. Int J Stroke 2008;3:130-7 (Pubitemid 351566847)
63. Lin R, Vora N, Zaidi S, et al. Mechanical approaches combined with intra-arterial pharmacological therapy are associated with higher recanalization rates than either intervention alone in revascularization of acute carotid terminus occlusion. Stroke 2009;40:2092-7
64. Castano C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836-40
65. Liebeskind DS. Aortic occlusion for cerebral ischemia: from theory to practice. Curr Cardiol Rep 2008;10:31-6
66. Noor R, Wang CX, Todd K, et al. Partial intra-aortic occlusion improves perfusion deficits and infarct size following focal cerebral ischemia. J Neuroimaging 2010;20:272-6
67. Hussain MS, Bhagat YA, Liu S, et al. DWI lesion volume reduction following acute stroke treatment with transient partial aortic obstruction. J Neuroimaging 2010; 20(4):379-81
68. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932-6
69. Khatri P, Neff J, Broderick JP, et al. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke 2005;36:2400-3 (Pubitemid 41566966)
70. Qureshi AI. New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002;50:1405-14
71. Larrue V, von Kummer RR, Muller A, Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438-41 (Pubitemid 32155231)
72. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82 (Pubitemid 46138121)
73. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119:2235-49